Why the study?
Does the prophylactic administration of autonomic blockers alter outcomes in patients with subarachnoid hemorrhage?
Does the prophylactic administration of autonomic blockers alter outcomes in patients with subarachnoid hemorrhage?
Despite the frequent occurrence of sympathetically-driven cardiac abnormalities and arrhythmias following subarachnoid hemorrhage, prophylactic autonomic blockade does not appear to significantly alter patient outcomes.
Answers are grounded in this paper and cite their sources.
Does not support routine prophylactic autonomic blockade after subarachnoid hemorrhage; leaves open targeted trials in high-arrhythmia-risk subgroups.
Electrocardiographic abnormalities, both morphological and rhythmic, are frequently seen in association with spontaneous subarachnoid hemorrhage. These changes, which often reflect subendocardial damage, seem to be caused by hypothalamic stimulation leading to an acute increase in sympathetic tone. As a result, potentially life-threatening ventricular arrhythmias may develop in subarachnoid hemorrhage patients. These arrhythmias have responded to sympathetic blocking agents, which may also have a protective effect on subendocardial tissue in this setting. There is no evidence that the prophylactic administration of propranolol or other autonomic blockers significantly alters outcome in these patients. Ultimate morbidity and mortality are clearly related to the degree of intracerebral-intraventricular hemorrhage and vasospasm. This article reviews experimental and clinical evidence regarding the causes of cardiac abnormalities after subarachnoid hemorrhage, the types of abnormalities most frequently seen, their relationship with subendocardial lesions, and the role of autonomic blockers. (Neurosurgery 18:101-106, 1986)
No takes yet. Share an insight, caveat, or question.
Marion et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: